These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
4. New series of isoniazid hydrazones linked with electron-withdrawing substituents. Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878 [TBL] [Abstract][Full Text] [Related]
6. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species. Disratthakit A; Doi N Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403 [TBL] [Abstract][Full Text] [Related]
7. Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible? Ho II; Chan CY; Cheng AF Antimicrob Agents Chemother; 2000 Jan; 44(1):39-42. PubMed ID: 10602720 [TBL] [Abstract][Full Text] [Related]
10. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
11. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis. Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533 [TBL] [Abstract][Full Text] [Related]
12. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids. Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706 [TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of quinolones and macrolides against mycobacteria. Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. Abate G; Hoffner SE Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701 [TBL] [Abstract][Full Text] [Related]
15. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum. Barrett MS; Jones RN; Erwin ME; Koontz FP Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632 [TBL] [Abstract][Full Text] [Related]
17. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases. Yamori S; Ichiyama S; Shimokata K; Tsukamura M Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364 [TBL] [Abstract][Full Text] [Related]
18. [Distribution and drug resistance of nontuberculous Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817 [No Abstract] [Full Text] [Related]
19. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium. Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana. Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]